Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Protein May Provide Early Biomarker for Prostate Cancer
Disease Discoveries

Protein May Provide Early Biomarker for Prostate Cancer

By Roger AndersonMay 30, 2014
Share
Facebook Twitter Email
Levels of the protein WDR5, seen with brown staining, are extremely low in normal prostate cells (top), but are significantly elevated in prostate cancer (bottom).

Elevated levels of a protein associated with cell cycle regulation may allow physicians to identify prostate cancer at its earliest stages.

Debabrata Chakravarti, PhD, professor of Obstetrics and Gynecology-Reproductive Biology Research, led the Northwestern Medicine study, which revealed the surprising role for WDR5.

“Our results showed that the overexpression of this protein may be necessary for the initiation, maintenance and growth of prostate cancer,” said Chakravarti, a member the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “If WDR5 is in fact a driver protein, we may also be able to develop a compound that would block a critical interaction and stymie the disease.”

The findings were published in Molecular Cell.

Prostate cancer is the second-leading cause of cancer deaths in North American men. In the United States, more than 225,000 are expected to be diagnosed with the disease this year and nearly 30,000 will die. Unlike breast cancer, the second-most common malignancy in American women, very few genetic abnormalities have been linked to the disease.

What scientists do know is that prostate cancer is stimulated by testosterone, a form of the male hormone androgen. The most common way to determine if a person has the malignancy is to perform a blood test for prostate specific antigen (PSA). The higher a man’s PSA level, the more likely it is that he has prostate cancer. However, false positives and negatives can occur.

“PSA is an outcome-based measure showing the possible presence of prostate cancer. We wanted to focus our efforts on the earliest events that may promote its development,” Chakravarti said. “Increased understanding of epigenetics indicates that the epigenome, or chemical changes to an organism’s DNA and its associated proteins called histones, is as important as or possibly even more important than our DNA.”

Debabrata Chakravarti, PhD, professor of Obstetrics and Gynecology-Reproductive Biology Research, was principal investigator of a study that revealed a specific protein involved in epigenetic regulation is elevated in prostate cancer. The findings could provide a new target for future therapeutic approaches. 

 

Unlike the genome, the epigenome can be dynamically altered by environmental conditions. What Chakravarti discovered is that WDR5 integrates androgen activity into the epigenome to stimulate prostate cancer growth.

“What this epigenetic change does is brings more dancers to the floor. One epigenetic change is helping establish another and together they are regulating genes that contribute to cancer growth,” Chakravarti said.

Scientists analyzed nearly 100 prostate samples and found WDR5 to be present at a very low level in normal tissue. However, the amount rises when prostate cancer is present.

To verify the role the protein plays, Chakravarti and colleagues removed WDR5 from prostate cancer cells in a petri dish. The result was that the cancer couldn’t grow, suggesting the possibility that a drug which could dampen this activity may be beneficial as treatment.

The work was done in collaboration with Northwestern Medicine colleagues Jian-Jun Wei, MD, and Grant Barish, MD, as well as Ishwar Radhakrishnan, PhD, professor of Molecular Biosciences.

“The finding is exciting because it tells us that the protein is directly involved in the prostate cancer process,” Chakravarti said. “If the upregualtion of WDR5 can be detected, prostate cancer will be revealed at its initial stages. A drug that could stop the epigenetic interaction would slow disease progression.”

Chakravarti’s laboratory is currently analyzing such possibilities.

The work is supported by National Cancer Institute grant RO1 CA133755, National Institute of Child Health and Human Development grant PO1 HD 57877 and the Robert H. Lurie Comprehensive Cancer Center.

Ji-Young Kim, lead author, Aurimas Vinckevicius and J. Brandon Parker also contributed to this study.

Cancer Cell and Developmental Biology Epigenetics Research
Share. Facebook Twitter Email

Related Posts

Coaxing Hair Growth in Aging Hair Follicle Stem Cells

Jun 9, 2023

New Therapeutic Target for Osteoarthritis Identified 

Jun 9, 2023

Largest Cell Map of Human Lung Reveals Insights Into Disease

Jun 8, 2023

Comments are closed.

Latest News

Coaxing Hair Growth in Aging Hair Follicle Stem Cells

Jun 9, 2023

New Therapeutic Target for Osteoarthritis Identified 

Jun 9, 2023

Largest Cell Map of Human Lung Reveals Insights Into Disease

Jun 8, 2023

McNally Honored with Walder Award

Jun 8, 2023

Biological Aging Increases Risk of Depression, Anxiety in Adults 

Jun 7, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
ANB05555
ANB08990
ANB09022
ANB09063
ANB09008
ANB08781
ANB08971
ANB09000
ANB08992
ANB09015
ANB09058
ANB09048

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.